U.K. Biodegradable Bone Graft Polymer Market: The Future of Orthopedic Advancements

The U.K. biodegradable bone graft polymer market is growing due to innovations in polymer technology, rising demand for minimally invasive surgeries, and biocompatibility.

U.K. Biodegradable Bone Graft Polymer Market Report Highlights

• By polymer, the synthetic segment dominated the U.K. biodegradable bone graft polymer market in 2024 and accounted for the highest revenue share.
• By polymer, the natural biodegradable bone graft polymer is anticipated to grow significantly during the forecast period.
• By application, the joint reconstruction segment dominated the U.K. biodegradable bone graft polymer market in 2024 and is expected to expand during the forecast period.
• By application, the spine segment is expected to grow fastest during the forecast period.

The U.K. biodegradable bone graft polymer market refers to the production, distribution, and application of biodegradable bone graft polymers, which are known as polymers that can decay under the presence or absence of oxygen in the environment. Biodegradable polymers are those that undergo microbially induced chain scission leading to mineralization. Specific conditions in terms of humidity, pH, oxygenation, and the presence of some metals are required to ensure the biodegradation of such polymers.

A graft polymer is a polymer compromising molecules with one or more species of block connected to the main chain as side chains, these side chains having constitutional or configurational features that differ from those in the main chain. Polymers have physical, mechanical, and chemical properties completely different from the other bone substitutes.

The polymers can be divided into synthetic polymers and natural polymers. These can be further divided into non-degradable and degradable types. In addition, these polymers are biocompatible, biodegradable, easily accessible, and cost-effective. Also, they possess inherent bioactive properties, such as wound healing and antimicrobial activity, further improving their potential in drug delivery for bone regeneration. PLGA is a highly used biodegradable bone grafting polymer that has the benefits of safety, ideal mechanical properties, biocompatibility, cytotoxicity, and controllable degradation.

Innovations in polymer technology and biocompatibility are driving the growth of the U.K. biodegradable bone graft polymer market. The use of biomaterials for medical applications is an attractive option, and the number of biomaterials being developed and tested is growing rapidly. The versatility and biocompatibility of polymers make them indispensable in modern biomaterials research and development. Innovations in polymer technology and biocompatibility have led to material creations with enhanced mechanical properties, improved optical clarity, better biocompatibility, and superior chemical resistance.

These innovations help to improve the reliability and functionality of devices and also open up new possibilities for their use in many fields including healthcare and others. Biocompatibility refers to the ability of a biomaterial to perform its desired function concerning a medical therapy without eliciting any undesirable local and systemic effects in the recipient or beneficiary of that therapy at the time of generating the most appropriate beneficial or cellular tissue in that specific situation and improving the clinically relevant performance of the therapy. Rising demand for minimally invasive procedures driving the growth of the U.K. biodegradable bone graft polymer market. Smaller incisions make for an easier recovery, with less pain and less risk of complications.

Generally, operations take longer when surgeons use minimally invasive methods due to there are many other steps, tools, and helpers involved. Minimally invasive surgical procedures are associated with less postoperative pain and discomfort than conventional methods. The smaller incisions and reduced tissue manipulation can cause much less trauma to the body, resulting in a more comfortable healing experience. Minimally invasive surgeries may be associated with a lower risk of complications than those associated with open surgeries. The risk of this treatment is low. Minimally invasive surgery benefits also include better cosmetic results with little scarring, quicker return to work, faster recovery, and less pain.

Rising incidences of dental and orthopedic surgeries are driving the growth of the U.K. biodegradable bone graft polymer market. Biodegradable polymers offer an opportunity to develop materials that can be used to improve guided tissue regeneration (GTR) to repair periodontal defects and guided bone regeneration (GBR) to prevent gum tissue from growing into bone cavities for tooth extraction or implant replacement. Nowadays, many bio- and nanomaterials are used in the field of dentistry and dental implantology. Biodegradable polymers are one of the primary and common biomaterials used for bone repair and tissue engineering. Their biodegradability and controlled degradation rates are highly beneficial for clinical applications.

According to Volza’s United Kingdom Import data, the United Kingdom imported 69 shipments of biodegradable plastic from January 2022 to December 2023. These supplies were supplied by 6 foreign exporters to 7 United Kingdom buyers, marking a growth rate of 2200% compared to the preceding twelve months.